Evidence map›Paper›PMID 32665580›Full record

ArticleNature communications2020

IRSp53 controls plasma membrane shape and polarized transport at the nascent lumen in epithelial tubules.

Sara Bisi, Stefano Marchesi, Abrar Rizvi, Davide Carra, Galina V Beznoussenko, Ines Ferrara, Gianluca Deflorian, Alexander Mironov, Giovanni Bertalot, Federica Pisati and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecular Insights into IQSEC2 Disease.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Interplay between mechanics and signalling in regulating cell fate.Nature reviews. Molecular cell biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Sara Bisi *IFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.
Stefano Marchesi *IFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.
Abrar Rizvi *IFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.
Davide CarraIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.ORCID http://orcid.org/0000-0003-0829-8668
Galina V BeznoussenkoIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.
Ines FerraraDepartment of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Via del Vespro 129, 90127, Palermo, Italy.
Gianluca DeflorianCogentech, S.R.L., Via Adamello 16, 20139, Milan, Italy.
Alexander MironovIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.
Giovanni BertalotEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Federica PisatiCogentech, S.R.L., Via Adamello 16, 20139, Milan, Italy.
Amanda OldaniIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.
Angela CattaneoCogentech, S.R.L., Via Adamello 16, 20139, Milan, Italy.
Ghazaleh SaberamoliIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.
Salvatore PeceEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Giuseppe VialeEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Angela BachiIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.ORCID http://orcid.org/0000-0003-4842-6556
Claudio TripodoIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.
Giorgio ScitaIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy. Giorgio.scita@ifom.eu.ORCID http://orcid.org/0000-0001-7984-1889
Andrea DisanzaIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.ORCID http://orcid.org/0000-0001-5101-2907
IFOM · ITRipamonti · ITUniversity of Milan · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is unclear whether the establishment of apical-basal cell polarity during the generation of epithelial lumens requires molecules acting at the plasma membrane/actin interface. Here, we show that the I-BAR-containing IRSp53 protein controls lumen formation and the positioning of the polarity determinants aPKC and podocalyxin. Molecularly, IRSp53 acts by regulating the localization and activity of the small GTPase RAB35, and by interacting with the actin capping protein EPS8. Using correlative light and electron microscopy, we further show that IRSp53 ensures the shape and continuity of the opposing plasma membrane of two daughter cells, leading to the formation of a single apical lumen. Genetic removal of IRSp53 results in abnormal renal tubulogenesis, with altered tubular polarity and architectural organization. Thus, IRSp53 acts as a membrane curvature-sensing platform for the assembly of multi-protein complexes that control the trafficking of apical determinants and the integrity of the luminal plasma membrane.

Indexed as

ActinsCell MembraneCell PolarityEpithelial CellsFemaleHumansMorphogenesisNerve Tissue ProteinsProtein Transportrab GTP-Binding ProteinsSialoglycoproteinsActinsBAIAP2 protein, humanNerve Tissue ProteinspodocalyxinRAB35 protein, humanrab GTP-Binding ProteinsSialoglycoproteins

Identifiers

PMID32665580
PMCPMC7360740
OpenAlexW3042717209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.